Search results
An Important History Lesson for Gene-Editing Investors
Motley Fool· 5 months agoThe history of biotechnology is full of examples of promising technologies that took decades to...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 5 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
What Are Biologics?
Health via Yahoo News· 5 months agoThe term “biologic” refers to a wide group of therapies used to treat many different types of medical conditions, such as rheumatoid arthritis and...
Why Gilead Sciences Stock Was a 5% Winner Today
Motley Fool· 2 years agoGilead Sciences (NASDAQ: GILD) stock was off to a good start this week, rising by more than 5% on Monday against the modest (0.4%) gain of the S&P 500 index. The prominent pharmaceutical company ...
